This result corroborates in vivo findings of reduced SV2A in the hippocampus of AD and MCI patients from SV2A PET imaging studies, and this suggests that SV2A plays an important role in the molecular mechanism of AD (Chen et al., 2018; Bastin et al., 2020). Here, SV2A is linked to Alzheimer disease.